M&A Deal Summary |
|
|---|---|
| Date | 2022-10-20 |
| Target | Corium Innovations |
| Sector | Life Science |
| Buyer(s) |
Gurnet Point Capital
Webster Equity Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Gurnet Point Capital is private investment group focused on the healthcare and life sciences sectors. The Firm looks to invest across all stages of product development through to commercialization and does so with an approach that is a hybrid of venture and private equity investing strategies. Gurnet Point Capital was formed in 2015 and is headquartered in Cambridge, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 7 |
| Sector (Life Science) | 4 of 5 |
| Type (Buyout (LBO, MBO, MBI)) | 2 of 2 |
| State (Michigan) | 1 of 1 |
| Country (United States) | 6 of 7 |
| Year (2022) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-23 |
Radius Health
Boston, Massachusetts, United States Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuro- orphan diseases, and oncology. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Radius Health was founded in 2003 and is based in Boston, Massachusetts. |
Buy | $890M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-06 |
Paratek Pharmaceuticals
King of Prussia, Pennsylvania, United States Paratek Pharmaceuticals is a bio-pharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek Pharmaceuticals was founded in 1996 and is based in King of Prussia, Pennsylvania. |
Buy | $462M |
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 6.8B USD |
| Size | Mega |
| Type | Sector Focused |
Webster Capital is a private equity firm that targets growth capital and buyout investments in profitable, middle-market healthcare and consumer companies. Prospective business characteristics of interest include differentiated products or services, distinctive brands, and loyal/repeat customers. Webster looks for companies generating sales of $20 to $200 million, EBITDA of $5 to $20 million, and valued up to $200 million. Webster Capital was formed in 2003 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 46 of 48 |
| Sector (Life Science) | 3 of 3 |
| Type (Buyout (LBO, MBO, MBI)) | 25 of 26 |
| State (Michigan) | 1 of 1 |
| Country (United States) | 44 of 46 |
| Year (2022) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-23 |
Radius Health
Boston, Massachusetts, United States Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuro- orphan diseases, and oncology. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Radius Health was founded in 2003 and is based in Boston, Massachusetts. |
Buy | $890M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-02-07 |
TriValley Medical Group
Murrieta, California, United States TriValley Medical Group is a physician platform that provides primary care and population health management services to Senior and Commercial members. TriValley Medical Group is based in Murrieta, California. |
Buy | - |
